30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Daniel Shoemaker

Track

Insider profile

Currently holds a position at Fate Therapeutics Inc

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 88% 68% 82%
Transactions
11 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Scientific Officer Fate Therapeutics Inc May 1, 2015 -
Chief Research Officer Fate Therapeutics Inc Jan. 1, 2015 - May 1, 2015
Chief Technology Officer Fate Therapeutics Inc Feb. 1, 2009 - Jan. 1, 2015
Daniel Shoemaker's trades of Fate Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-03-09 2021-03-08
PlS Planned sale
78,296 +42.5%
290.01
US$4,909,612 		78,296 +42.5% 290.01 US$4,909,612
2021-03-09 2021-03-08
PlS Planned sale
97,895 +5.3%
82.44
US$3,553,197 		97,895 +5.3% 82.44 US$3,553,197
2021-03-09 2021-03-08
PlS Planned sale
77,881 +32.1%
398.82
US$4,885,503 		77,881 +32.1% 398.82 US$4,885,503
2021-03-09 2021-03-08
PlS Planned sale
2,480 -3.0%
83.46
US$206,989 		2,480 -3.0% 83.46 US$206,989
2021-03-09 2021-03-08
PlS Planned sale
2,993 -3.5%
81.60
US$244,224 		2,993 -3.5% 81.60 US$244,224
2021-03-09 2021-03-08
PlS Planned sale
5,174 -5.7%
80.73
US$417,722 		5,174 -5.7% 80.73 US$417,722
2021-03-09 2021-03-08
PlS Planned sale
4,627 -4.9%
79.58
US$368,236 		4,627 -4.9% 79.58 US$368,236
2021-03-09 2021-03-08
PlS Planned sale
3,298 -3.4%
78.60
US$259,236 		3,298 -3.4% 78.60 US$259,236
2021-01-12 2021-01-11
S Sale
871 -1.0%
109.65
US$95,509 		871 -1.0% 109.65 US$95,509
2021-01-12 2021-01-11
S Sale
1,050 -1.2%
110.76
US$116,296 		1,050 -1.2% 110.76 US$116,296
2021-01-12 2021-01-11
S Sale
1,332 -1.5%
111.62
US$148,673 		1,332 -1.5% 111.62 US$148,673
2021-01-12 2021-01-08
S Sale
151 -0.2%
114.76
US$17,328 		151 -0.2% 114.76 US$17,328
2021-01-12 2021-01-08
S Sale
872 -1.0%
115.80
US$100,977 		872 -1.0% 115.80 US$100,977
2021-01-12 2021-01-08
S Sale
2,451 -2.7%
117.15
US$287,144 		2,451 -2.7% 117.15 US$287,144
2021-01-12 2021-01-08
S Sale
2,755 -3.0%
117.60
US$323,985 		2,755 -3.0% 117.60 US$323,985
2020-11-16 2020-11-16
PlS Planned sale
14,781 -13.7%
52.40
US$774,514 		14,781 -13.7% 52.40 US$774,514
2020-11-16 2020-11-16
PlS Planned sale
5,287 -4.7%
51.60
US$272,825 		5,287 -4.7% 51.60 US$272,825
2020-11-16 2020-11-16
PlS Planned sale
4,932 -4.2%
50.37
US$248,407 		4,932 -4.2% 50.37 US$248,407
2020-09-16 2020-09-14
PlS Planned sale
5,713 -4.6%
37.12
US$212,074 		5,713 -4.6% 37.12 US$212,074
2020-09-16 2020-09-14
PlS Planned sale
17,887 -12.6%
36.11
US$645,909 		17,887 -12.6% 36.11 US$645,909
2020-09-16 2020-09-14
PlS Planned sale
1,400 -1.0%
35.40
US$49,557 		1,400 -1.0% 35.40 US$49,557
2020-01-10 2020-01-08
S Sale
5,700 -3.8%
20.70
US$117,986 		5,700 -3.8% 20.70 US$117,986
2020-01-02 2019-12-30
PlS Planned sale
100 -0.1%
20.34
US$2,034 		100 -0.1% 20.34 US$2,034
2020-01-02 2019-12-30
PlS Planned sale
24,900 -16.7%
19.49
US$485,393 		24,900 -16.7% 19.49 US$485,393
2019-10-16 2019-10-15
S Sale
11,800 -8.7%
14.29
US$168,592 		11,800 -8.7% 14.29 US$168,592
2019-06-28 2019-06-27
PlS Planned sale
12,500 -8.4%
20.21
US$252,610 		12,500 -8.4% 20.21 US$252,610
2019-03-29 2019-03-28
PlS Planned sale
12,500 -8.4%
16.94
US$211,702 		12,500 -8.4% 16.94 US$211,702
2017-10-17 2017-10-16
S Sale
700 -0.8%
4.08
US$2,856 		700 -0.8% 4.08 US$2,856
2017-10-17 2017-10-13
S Sale
12,525 -12.1%
3.86
US$48,346 		12,525 -12.1% 3.86 US$48,346